The Importance of Having Investors as Customers

Interview with Eric Stone, CEO of Velano Vascular

Eric Stone cofounded Velano Vascular with Dr. Pitou Devgon, an internal medicine physician. Velano’s first device, PIVO, enables needle-free blood draws directly from peripheral IV catheters. Velano Vascular is backed by a series of well-respected investment firms, leading U.S. health systems, and dozens of health industry veterans.

Before starting Velano Vascular, Stone most recently served as VP of Sales and Marketing for MolecularHealth. Prior to that, he helped launch the world’s first bioabsorable stent for Abbott while working out of their California and Belgium offices. He was also a founding member of Model N’s Life Sciences division and began his career in software marketing with Trilogy. Eric also holds advanced degrees in Business Administration and Education from the Wharton School and Harvard University, respectively. He earned a BA degree in English and Psychology from the University of Pennsylvania.

Interview Highlights with Eric Stone

  • Why Eric has been referred to as the “Steve Jobs of drawing blood”.

  • How PIVO compares to the current standard of care for blood draws.

  • What brought Eric into healthcare after starting his career in software marketing.

  • Why Eric pursued both an MBA and Masters in Education and how both degrees have benefited him both personally and professionally.

  • The biggest lessons Eric learned while launching the first bioabsorbable stent with Abbott.

  • How Eric first connected with Dr. Devgon and the origin story for the PIVO device.

  • The four milestones Eric and his team accomplished in taking the PIVO device from initial idea to commercial prototype.

  • Eric’s approach to garnering financial support from healthcare systems and raising money for Velano Vascular.

  • How the PIVO device fits into the value-based healthcare equation.

  • Eric’s favorite business book, the CEO he admires most, and what he’d tell his 25-year-old self.

Premium Members Only

Premium Members Only

You don't have access to this post, but if you become a premium member, you'll be able to see the whole thing, including many other exclusive benefits.

You don't have access to this post, but if you become a premium member, you'll be able to see the whole thing, including many other exclusive benefits.

You May Like These Articles

Medsider Premium

Become a premium member and unlock access to exclusive Medsider benefits.

Medsider Mentors

Medsider Mentors

Medsider Playbooks

Medsider Playbooks

Playbook

A Guide to Widespread Adoption in Medtech

In medtech, developing novel, impactful technology is often just the starting line. The real race begins when you try to integrate your solution into the often-resistant healthcare system – a hurdle that has tripped up countless promising companies. Here are the key strategies and lessons from five veterans in the medtech space on how to overcome this hurdle.

Copyright © Medsider 2024 • All rights reserved.

Subscribe

Sign In

Suggest a Guest

Copyright © Medsider 2024 • All rights reserved.

Subscribe

Sign In

Suggest a Guest

Copyright © Medsider 2024 • All rights reserved.

Subscribe

Sign In

Suggest a Guest